<p>Documented retrieval actions after treatment interruptions among retreatment TB patients who ultimately defaulted from treatment, India 2006 (N = 1,141).</p
The characteristics of patients receiving tuberculosis retreatment cycles, including those with recu...
Multidrug-resistant Tuberculosis (MDR-TB) is a rising global threat to public health and concerted e...
The reasons that patients with multidrug-resistant tuberculosis (MDR TB) miss treatment are multi-fa...
<p>Duration of treatment (in days) completed among re-treatment TB patients who ultimately defaulted...
BACKGROUND: In 2009, nearly half (289,756) of global re-treatment TB notifications are from India; n...
In 2009, nearly half (289,756) of global re-treatment TB notifications are from India; no nationally...
Under India's Revised National Tuberculosis Control Programme (RNTCP), >15% of previously-treated pa...
Under India's Revised National Tuberculosis Control Programme (RNTCP), >15% of previously-treated pa...
In 2009, nearly half (289,756) of global re-treatment TB notifications are from India; no nationally...
Background: M .tuberculosis is an ancient infectious killer that still remains one of the leading ca...
Background: M .tuberculosis is an ancient infectious killer that still remains one of the leading ca...
Background: M .tuberculosis is an ancient infectious killer that still remains one of the leading ca...
<p>Post treatment outcomes of the patients lost from DR-TB treatment (January 2009-July 2013).</p
<p>Web of multifactorial causation for lost to follow- up among MDR-TB Treatment, Nagpur.</p
Background: Pretreatment loss to follow-up (PTLFU) is a barrier to tuberculosis (TB) control in Indi...
The characteristics of patients receiving tuberculosis retreatment cycles, including those with recu...
Multidrug-resistant Tuberculosis (MDR-TB) is a rising global threat to public health and concerted e...
The reasons that patients with multidrug-resistant tuberculosis (MDR TB) miss treatment are multi-fa...
<p>Duration of treatment (in days) completed among re-treatment TB patients who ultimately defaulted...
BACKGROUND: In 2009, nearly half (289,756) of global re-treatment TB notifications are from India; n...
In 2009, nearly half (289,756) of global re-treatment TB notifications are from India; no nationally...
Under India's Revised National Tuberculosis Control Programme (RNTCP), >15% of previously-treated pa...
Under India's Revised National Tuberculosis Control Programme (RNTCP), >15% of previously-treated pa...
In 2009, nearly half (289,756) of global re-treatment TB notifications are from India; no nationally...
Background: M .tuberculosis is an ancient infectious killer that still remains one of the leading ca...
Background: M .tuberculosis is an ancient infectious killer that still remains one of the leading ca...
Background: M .tuberculosis is an ancient infectious killer that still remains one of the leading ca...
<p>Post treatment outcomes of the patients lost from DR-TB treatment (January 2009-July 2013).</p
<p>Web of multifactorial causation for lost to follow- up among MDR-TB Treatment, Nagpur.</p
Background: Pretreatment loss to follow-up (PTLFU) is a barrier to tuberculosis (TB) control in Indi...
The characteristics of patients receiving tuberculosis retreatment cycles, including those with recu...
Multidrug-resistant Tuberculosis (MDR-TB) is a rising global threat to public health and concerted e...
The reasons that patients with multidrug-resistant tuberculosis (MDR TB) miss treatment are multi-fa...